Masimo Corporation (MASI)

Check out top investors' recommendation for MASI
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin, hemoglobin, pleth variability index, respiration rate, Halo Index, and In Vivo Adjustment. It develops, manufactures, and markets a family of patient monitoring solutions comprising circuit boards, monitors, sensors, and cables; Masimo Patient SafetyNet, a remote monitoring and clinician notification solution; and various software products. The company sells its products to hospitals, emergency medical response organizations, and alternate care market through its direct sales force and distributors, as well as to original equipment manufacturer partners. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Matthew Taylor National Bank Financial Buy   Mar 09, '18     97.00  Mar 09, '19  N/A 
Sean Lavin Lazard Capital Markets Buy   Aug 14, '17     100.00  Aug 14, '18  N/A 
Rick Wise Stifel Nicolaus & Company, Inc. Buy   Jul 10, '17     105.00  Jul 10, '18  N/A 
Lawrence Keusch Raymond James Buy   Jun 01, '16       Jun 01, '17  N/A 
Matt Dolan Roth Capital Partners LLC Buy   May 05, '16     50.00  May 05, '17  N/A 
William Quirk Piper Jaffray Buy   May 05, '16       May 05, '17  N/A 
Lawrence Keusch Raymond James Buy   Jan 06, '16   38.28  46.00  Jan 06, '17  76.38% 
Matt Dolan Roth Capital Partners LLC Buy   Aug 05, '15   43.61  46.00  Aug 05, '16  31.69% 
Lawrence Keusch Raymond James Buy   Jun 12, '15   38.84  46.00  Jun 12, '16  34.14% 
Matt Dolan Roth Capital Partners LLC Buy   May 07, '15   34.94  38.00  May 07, '16  31.91% 
Tao Levy Wedbush Securities Inc. Buy   Jan 07, '15   27.04    Jan 07, '16  41.57% 
Matt Dolan Roth Capital Partners LLC Buy   Oct 31, '13   25.62  32.00  Oct 31, '14  -2.50% 
Matthew Dodds Citi Sell   Feb 09, '12   20.78  20.00  Feb 09, '13  8.30% 
William Quirk Piper Jaffray Buy   Nov 28, '11   18.34  31.00  Nov 28, '12  10.25% 
Matthew Dodds Citi Sell   Aug 10, '11   21.79  24.00  Aug 10, '12  2.89% 
Matthew Dodds Citi Sell   Jan 31, '11   28.57  28.00  Jan 31, '12  28.74%